PeptideDB

GSK-3β inhibitor 25

CAS: 75620-25-6 F: C16H15NOS W: 269.36

GSK-3β inhibitor 25 (Compound 6h) exhibits a weak inhibitory activity against GSK-3β wih an IC50>100 μM.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity GSK-3β inhibitor 25 (Compound 6h) exhibits a weak inhibitory activity against GSK-3β wih an IC50>100 μM[1].
CAS 75620-25-6
Formula C16H15NOS
Molar Mass 269.36
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Zhang P, et al., Design, synthesis and biological evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β). Eur J Med Chem. 2013 Mar;61:95-103.